SEC Comment Letter 0000000000-23-012723 to WORK Medical Technology Group LTD (WOK)
WORK Medical Technology Group LTD
Date: Nov. 20, 2023 · CIK: 0001929783 · Accession: 0000000000-23-012723
AI Filing Summary & Sentiment
File numbers found in text: 333-271474
Letter
United States securities and exchange commission logo November 20, 2023 Shuang Wu Chief Executive Officer WORK Medical Technology LTD Floor 23, No. 2 Tonghuinan Road Xiaoshan District, Hangzhou City, Zhejiang Province The People’s Republic of China Re:WORK Medical Technology LTD Amendment No. 5 to Registration Statement on Form F-1 Filed November 6, 2023 File No. 333-271474 Dear Shuang Wu: We have reviewed your amended registration statement and have the following comment(s). Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our October 12, 2023 letter. Amendment No. 5 to Registration Statement on Form F-1 General 1.It appears you will be requesting effectiveness of your F-1 registration statement before completing the CSRC process. Please confirm in writing that you will notify us promptly of any changes to your disclosure regarding or requested by the CSRC.
FirstName LastNameShuang Wu Comapany NameWORK Medical Technology LTD November 20, 2023 Page 2 FirstName LastName Shuang Wu WORK Medical Technology LTD November 20, 2023 Page 2 Please contact Michael Fay at 202-551-3812 or Daniel Gordon at 202-551-3486 if you have questions regarding comments on the financial statements and related matters. Please contact Margaret Schwartz at 202-551-7153 or Katherine Bagley at 202-551-2545 with any other questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Ying Li, Esq.
Show Raw Text
United States securities and exchange commission logo
November 20, 2023
Shuang Wu
Chief Executive Officer
WORK Medical Technology LTD
Floor 23, No. 2 Tonghuinan Road
Xiaoshan District, Hangzhou City, Zhejiang Province
The People’s Republic of China
Re:WORK Medical Technology LTD
Amendment No. 5 to Registration Statement on Form F-1
Filed November 6, 2023
File No. 333-271474
Dear Shuang Wu:
We have reviewed your amended registration statement and have the following
comment(s).
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response.
After reviewing any amendment to your registration statement and the information you
provide in response to this letter, we may have additional comments. Unless we note otherwise,
any references to prior comments are to comments in our October 12, 2023 letter.
Amendment No. 5 to Registration Statement on Form F-1
General
1.It appears you will be requesting effectiveness of your F-1 registration statement before
completing the CSRC process. Please confirm in writing that you will notify us promptly
of any changes to your disclosure regarding or requested by the CSRC.
FirstName LastNameShuang Wu
Comapany NameWORK Medical Technology LTD
November 20, 2023 Page 2
FirstName LastName
Shuang Wu
WORK Medical Technology LTD
November 20, 2023
Page 2
Please contact Michael Fay at 202-551-3812 or Daniel Gordon at 202-551-3486 if you
have questions regarding comments on the financial statements and related matters. Please
contact Margaret Schwartz at 202-551-7153 or Katherine Bagley at 202-551-2545 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Ying Li, Esq.